A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin).
Daniel Martin KlotzTheresa LinkPauline WimbergerJan Dominik KuhlmannPublished in: Clinical chemistry and laboratory medicine (2023)
We present a robust predictive/prognostic model for ovarian cancer, which could readily be implemented into routine diagnostics in order to identify ovarian cancer patients at high risk of recurrence.